Frontiers in Digital Health · 2023 · 39 citations · 69 references
MedicineBioinformaticsOncologyGynecologic OncologyMachine LearningMolecular OncologyCancer BiomarkersDecision TreesMolecular Tumor ProfilingNoncoding Rna In CancerOvarian CancerTumor ClassificationCirculating BiomarkersCirculating Rna BiomarkersDiagnostic BiomarkersMachine Learning Biomarker DiscoveryMachine Learning ClassificationNon-coding Rna BiomarkersNovel Circulating BiomarkersOvarian Cancer Biomarkers
Introduction: In gynecologic oncology, ovarian cancer is a great clinical challenge. Because of the lack of typical symptoms and effective biomarkers for noninvasive screening, most patients develop advanced-stage ovarian cancer by the time of diagnosis. MicroRNAs (miRNAs) are a type of non-coding RNA molecule that has been linked to human cancers. Specifying diagnostic biomarkers to determine non-cancer and cancer samples is difficult. Methods: By using Boruta, a novel random forest-based feature selection in the machine-learning techniques, we aimed to identify biomarkers associated with ovarian cancer using cancerous and non-cancer samples from the Gene Expression Omnibus (GEO) database: GSE106817. In this study, we used two independent GEO data sets as external validation, including GSE113486 and GSE113740. We utilized five state-of-the-art machine-learning algorithms for classification: logistic regression, random forest, decision trees, artificial neural networks, and XGBoost. Results: Four models discovered in GSE113486 had an AUC of 100%, three in GSE113740 with AUC of over 94%, and four in GSE113486 with AUC of over 94%. We identified 10 miRNAs to distinguish ovarian cancer cases from normal controls: hsa-miR-1290, hsa-miR-1233-5p, hsa-miR-1914-5p, hsa-miR-1469, hsa-miR-4675, hsa-miR-1228-5p, hsa-miR-3184-5p, hsa-miR-6784-5p, hsa-miR-6800-5p, and hsa-miR-5100. Our findings suggest that miRNAs could be used as possible biomarkers for ovarian cancer screening, for possible intervention.
69
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Xavier Robin, Natacha Turck, Alexandre Hainard et al. · BMC Bioinformatics · 2011 · 14K citations · Full text
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text
Feature Selection with the<b>Boruta</b>Package
Miron B. Kursa, Witold R. Rudnicki · Journal of Statistical Software · 2010 · 5.2K citations · Full text
Gary S. Collins, Johannes B. Reitsma, Douglas G. Altman et al. · Annals of Internal Medicine · 2015 · 2.9K citations · Full text
Andreas du Bois, Eric Pujade‐Lauraine, Philipp Harter et al. · Cancer · 2009 · 1.6K citations · Full text